News

EjectDelay’s active ingredient is a fast absorbing and vanishing gel formulation with the active drug benzocaine at 7.5% designed to reduce transfer to the partner. A total of

The transaction will provide Ohr Pharmaceutical with a proprietary, patent protected, sustained release technology platform under development as well as a pipeline of pre-clinical sustained release drug product

Donnatal is available in two formulations: immediate release Donnatal Tablets, and immediate release Donnatal Elixir, a fast acting liquid. For decades, Donnatal has delivered gentle relief from the

OxThera holds proprietary rights to pharmaceutical preparations and their use for treatment of hyperoxaluria in eight patent families. The newly granted US patents have numbers 8,486,389 and 8,545,836.

BRF funding will expand that study to evaluate whether the "dose" of physical activity predicts the magnitude of response. "The early studies across the neuroscience community do indicate

Neos has developed an extended release (XR) amphetamine oral disintegrating tablet (ODT) and an extended release amphetamine liquid suspension both of which are expected to be filed for

Projects supported by the fund are likely to involve scientists from the two organisations working side by side, either within the MRC LMB at the Cambridge Biomedical Campus,

About 375 patients with type 2 diabetes are expected to be enrolled in the trial, which will be performed by the company’s development partner, Eli Lilly and Company.

In the study, darapladib did not achieve the primary endpoint of a reduction of major coronary events versus placebo when added to standard of care. The overall safety